Risk of Cardiovascular Events after Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Patients Receiving Long-Term Low-Dose Azithromycin

Tommaso Bucci; Dennis Wat; D. Nazareth; Sarah Sibley; Dan Wootton; Professor Gregory Lip; Freddy Frost

doi:10.1164/rccm.202309-1699le

Back

Risk of Cardiovascular Events after Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Patients Receiving Long-Term Low-Dose Azithromycin

Letter 2024 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2023

Does azithromycin modulate cardiovascular risk following acute pulmonary exacerbations of chronic obstructive pulmonary disease?

Freddy Frost, Tomasso Bucci, Dennis Wat, Sarah Sibley, David Green, Professor Gregory Lip

Article2023

Risk of major cardiovascular events and bleeding in atrial fibrillation patients with chronic obstructive pulmonary disease treated with low dose azithromycin prophylaxis

Tommaso Bucci, Freddy Frost, D Wat, Sarah Sibley, Pasquale Pignatelli, Daniel J. Green, Professor Gregory Lip

Article2024

Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: Results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in Italy

Silvia Calabria, Giulia Ronconi, Letizia Dondi, Leonardo Dondi, Irene Dell’Anno, Clémentine Nordon, Kirsty Rhodes, Paola Rogliani, Francesco Dentali, Nello Martini, Aldo Maggioni

Article2025

The risk of acute exacerbations of chronic obstructive pulmonary disease following acute myocardial infarction

Mert Kaşkal, Tommaso Bucci, Steven Ho Man Lam, Professor Gregory Lip, Freddy Frost

Article2007

Exacerbations of chronic obstructive pulmonary disease

Bartolomé R. Celli, Peter J Barnes